Listed

Fresenius Medical Care AG: Form 20-F for the period ended Dec 31, 2011

Filed with the SEC on Feb 23, 2012 and accepted by EDGAR at Feb 23, 2012, 16:23 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2011-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue12 months2011-01-01 to 2011-12-31$8.27bnus-gaap:CostOfRevenue
Gross profit12 months2011-01-01 to 2011-12-31$4.52bnus-gaap:GrossProfit
Research and development12 months2011-01-01 to 2011-12-31$110.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2011-01-01 to 2011-12-31$2.37bnus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2011-01-01 to 2011-12-31$2.07bnus-gaap:OperatingIncomeLoss
Interest expense12 months2011-01-01 to 2011-12-31$356.4mus-gaap:InterestExpense
Income tax12 months2011-01-01 to 2011-12-31$601.1mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2011-01-01 to 2011-12-31$1.07bnus-gaap:NetIncomeLoss
Diluted EPS12 months2011-01-01 to 2011-12-31$3.51us-gaap:EarningsPerShareDiluted
Basic EPS12 months2011-01-01 to 2011-12-31$3.54us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2011-01-01 to 2011-12-31300,808,487 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2011-01-01 to 2011-12-31$1.45bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2011-01-01 to 2011-12-31$597.9mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid12 months2011-01-01 to 2011-12-31$280.6mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2011-12-31$457.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2011-12-31$5.70bnus-gaap:AssetsCurrent
Total assetsAt period end2011-12-31$19.53bnus-gaap:Assets
Current liabilitiesAt period end2011-12-31$4.26bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2011-12-31$11.06bnus-gaap:Liabilities
Long-term debtAt period end2011-12-31$5.49bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2011-12-31$126.8mus-gaap:DebtCurrent
Short-term borrowingsAt period end2011-12-31$98.8mus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2011-12-31$7.90bnus-gaap:StockholdersEquity
Shares outstandingAt period end2011-12-31300,164,922 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0000950123-12-002984. Last ingested by Listed: Nov 14, 2026, 17:40 ET. Listed shows no prices and gives no investment advice.